Abstract
The 13C-MFA experiments require an optimal design since the precision or confidence intervals of the estimated flux levels depends on factors such as the composition of 13C-labeled carbon sources, as well as the metabolic flux distribution of interest. In this study, useful compositions of 13C-labeled glucose for 13C-metabolic flux analysis (13C-MFA) of Escherichia coli are investigated using a computer simulation of the stable isotope labeling experiment. Following the generation of artificial mass spectra datasets of amino acid fragments using five literature-reported flux distributions of E. coli, the best fitted flux distribution and the 95% confidence interval were estimated by the 13C-MFA procedure. A comparison of the precision scores showed that [1, 2-13C]glucose and a mixture of [1-13C] and [U-13C]glucose at 8:2 are one of the best carbon sources for a precise estimation of flux levels of the pentose phosphate pathway, glycolysis and the TCA cycle. Although the precision scores of the anaplerotic and glyoxylate pathway reactions were affected by both the carbon source and flux distribution, it was also shown that the mixture of non-labeled, [1-13C], and [U-13C]glucose at 4:1:5 was specifically effective for the flux estimation of the glyoxylate pathway reaction. These findings were confirmed by wet 13C-MFA experiments.
Keywords: 13C-metabolic flux analysis, Design of experiment, 13C-labeling experiment, Escherichia coli, Computer simulation
Highlights
-
•
Useful compositions of 13C-labeled glucose are investigated for 13C-MFA of E. coli.
-
•
Computer simulations revealed that [1,2-13C] was one of the best first choices.
-
•
Mixture of non-labeled, [1-13C] and [U-13C] at 0:8:2 was also suitable for 13C-MFA.
-
•
Mixture at 4:1:5 was specifically effective for estimation of glyoxylate pathway.
-
•
The wet 13C-MFA experiments of E. coli confirmed the findings.
1. Introduction
The 13C-metabolic flux analysis (13C-MFA) is a tool for detailed understanding of intracellular carbon flux distributions of microbial and mammalian cells (Antoniewicz, 2013b, Antoniewicz, 2015, Wiechert, 2001, Wittmann, 2007, Zamboni et al., 2009). Following cultivation of the cells in medium containing 13C-labeled carbon sources, a metabolic flux distribution was estimated from the 13C-labeling patterns of intracellular metabolites (mass isotopomer distribution (MID)) (Antoniewicz et al., 2007b, Zamboni et al., 2009). The 13C-MFA has been originally developed for metabolic engineering of microbes (Costenoble et al., 2007, Shirai et al., 2007, Wasylenko and Stephanopoulos, 2015), and recently applied to the quantitative analysis of cell metabolism in various fields of systems biology (Christen and Sauer, 2011, Haverkorn van Rijsewijk et al., 2011, Shimizu, 2004) and cancer research (Gaglio et al., 2011, Hiller and Metallo, 2013).
13C-MFA experiments require an optimized experimental design since the precision or confidence interval of the estimated flux levels depends on factors including (i) the structure of the metabolic network model, (ii) the composition of 13C-labeled carbon sources, (iii) the available intracellular metabolites for the MID measurement, (iv) the number of experiments performed, and (v) the metabolic flux distribution of interest (Antoniewicz, 2013a). In the case of 13C-MFA of E. coli, a metabolic model has been well established and a list of available fragment ions has been reported for gas chromatography-mass spectrometry (GC–MS) analysis of amino acids (Antoniewicz et al., 2007a; Okahashi et al., 2014). Despite the best precision for the flux estimation having been attained by introducing parallel labeling experiments using 14 carbon sources (Crown et al., 2015, Leighty and Antoniewicz, 2013), further investigation of the useful 13C-labeled carbon sources is still needed since single labeling experiments have been performed for the 13C-MFA of E. coli.
The selection of 13C-labeled carbon tracers has, however, bothered the design of 13C-MFA experiments. This is because a strict optimization of 13C-labeled carbon sources depends on the metabolic flux distribution inside of the target cells, a factor that is usually unknown before a 13C-MFA experiment. Furthermore, the relationship between precision of flux estimations, composition of [13C]glucose (tracers) and the metabolic flux distribution remains unclear. Thus, the best first choice of a 13C-labeled carbon source for the precise estimation of any given flux distribution in the whole metabolic network is also unclear. Recent optimization efforts via the analysis of experimental data or computer simulation of 13C-MFA experiments revealed that [4,5,6-13C]glucose and the mixture of [1-13C] and [U-13C]glucose at a ratio of 8:2 are suitable for the flux determinations of the TCA cycle and the pentose phosphate pathway, respectively (Crown et al., 2015, Millard et al., 2014, Shupletsov et al., 2014). Further investigation considering the other flux distributions is however needed, since the tracer compositions were optimized for one metabolic flux distribution of E. coli.
In this study, the relationship among the precision of metabolic flux estimation, composition of [13C]glucose and the metabolic flux distribution was investigated using a computer simulation of the 13C-labeling experiment of the 13C-MFA of E. coli. A series of artificial MID datasets of amino acid fragments were generated for various compositions of [13C]glucose using the literature reported flux distributions of E. coli. Useful compositions of [13C]glucose were investigated by comparing 95% confidence intervals of estimated flux distributions. Similar approach was employed to optimize the best composition of 13C-glucose for the metabolic flux analysis of Synechocystis sp. PCC6803 under the mixotrophic condition (Arauzo-Bravo and Shimizu, 2003). In this study, the simulation was performed for five literature reported flux distributions of E. coli to investigate the relationship between the precision of metabolic flux estimation, composition of [13C]glucose and the metabolic flux distribution, from which compositions of useful [13C]glucose were discussed. The results showed that [1,2-13C]glucose and the mixture of [1-13C] and [U-13C]glucose at 8:2 are the most useful first choices for a precise estimation of flux level, whereas the anaplerotic and glyoxylate pathway reactions are affected by both the carbon source and flux distribution. The simulation results were confirmed experimentally by 13C-MFA of E. coli.
2. Materials and methods
2.1. Software
All procedures for the simulation of 13C-MFA experiments were performed using a Python version of OpenMebius (Kajihata et al., 2014) implemented in Python 2.7.9 with NumPy 1.9.1, SciPy 0.4.2, PyOpt 1.2, and parallel Python 1.6.4 modules. Metabolic fluxes were estimated by minimizing the residual sum of squares (RSS) between experimentally measured and simulated MIDs using the SLSQP (sequential least squares programming) function implemented in PyOpt 1.2 (Perez et al., 2012). The optimizing function is described as
(1) |
where is the MID of the ith measured metabolite, is the estimated MID of the corresponding metabolite, is the standard deviation of MID measurement, and N is the number of metabolites used for flux estimation. Multiple jobs for the metabolic flux estimations were executed using the distributed computing function of parallel Python 1.6.4. For all 13C-MFA, the flux levels of glucose uptake, excretion of products, and biomass synthesis were fixed to the measured or literature reported values. Ranges of 95% confidence interval were determined by the grid search method (Antoniewicz et al., 2006).
2.2. Precision score
Precision scoring was used to evaluate estimation accuracy (Metallo et al., 2009). A normalized range is calculated for each flux using the formula:
(2) |
where ui, vi, li and ri are upper bound, the estimated flux, lower bound and normalized range for the ith flux. The individual ranges are converted into scores using a negative exponential function.
(3) |
The individual score (Si) were summed into an overall score (SSum).
(4) |
Larger Si and SSum levels indicate narrower confidence intervals or more precise estimation of determined flux levels of a reaction and the whole metabolic network, respectively.
2.3. Optimization of the 13C tracer by computational simulation of 13C-MFA
The computer simulation of a 13C-MFA experiment was conducted by the following procedure (Fig. 1). Step 1: The intracellular flux distribution (Fig. 1a), the consumption and production rates (Fig. 1b) data were obtained from the literature. In this study, the 13C-MFA studies for (A) a continuous culture of E. coli MG1655 (Okahashi et al., 2014), (B) a batch cultivation of MG1655 (Crown et al., 2015), (C) a batch cultivation of a pgiΔ deletion strain (Toya et al., 2010), (D) a batch cultivation of a pykΔ deletion strain (Toya et al., 2010), and (E) a batch cultivation of E. coli BW25113 (Toya et al., 2007) were used (Supplementary data S1). Step 2: A composition of [13C]glucose was arbitrarily selected (Fig. 1c). Step 3: The theoretical MIDs were calculated for the 24 fragments of amino acids shown in Table 1, and then the Gaussian noise at 1% levels was added to produce artificially measured MID data (Fig. 1d). Step 4: A metabolic flux distribution (Fig. 1e) and its 95% confidence intervals (Fig. 1f) were estimated by the method mentioned above. The standard deviations of MID measurements were set at 0.01. The metabolic networks of E. coli consisting of glycolysis, pentose phosphate pathway, TCA cycle, anaplerotic pathway, glyoxylate pathway, and Entner-Doudoroff pathway were employed following the original literature (Supplementary data S1). The metabolic models of the literature data (D) and (E) do not include glyoxylate and Entner-Doudoroff pathway related reactions (Toya et al., 2007, Toya et al., 2010). Step 5: An accuracy score Si (Fig. 1g) was determined for each reaction i by Eq. (3). Step 6: The sum of Si of all reactions, Ssum, was calculated by Eq. (4). The calculation of one Ssum value requires approximately 40 min with this procedure on a PC cluster running Windows Server 2008 (Xeon® CPU E7-8870, L5460 and AMD Opteron™ Processor 6238, 100 cores in total).
Table 1.
Ala | Val | Leu | Ile | Gly | Ser | Phe | Tyr | Asp | Thr | Glu | |
---|---|---|---|---|---|---|---|---|---|---|---|
[M-57]+ | + | + | + | + | + | + | + | + | |||
[M-85]+ | + | + | + | + | + | + | + | + | |||
[M-159]+ | + | + | + | + | + | ||||||
[f302]+ | + | + | + |
2.4. 13C-metabolic flux analysis
[1-13C]glucose (99%) and [U-13C]glucose (99%) were purchased from Cambridge Isotope Laboratory (Andover, MA). E. coli K-12 MG1655 was precultured using 100 mL of M9 medium containing 3 g/L glucose in 500 mL Sakaguchi flasks at 37 °C with shaking at 120 rpm. At OD600=1.0, the preculture was transferred to the main cultures. The main cultures were carried out at identical conditions (initial OD600=0.01), except for using mixtures of non-labeled, [1-13C], and [U-13C]glucose at a ratio of 0:8:2 and 4:1:5 as the carbon sources. Biomass samples were taken 6.5 h after main cultures started. The concentrations of cells, glucose, and acetate in the culture medium were analyzed by the previously described method (Okahashi et al., 2014).
The analysis of 13C-labeled proteinogenic amino acids was performed as described previously (Antoniewicz et al., 2007a, Okahashi et al., 2014). In short, proteinogenic amino acids were obtained by acid hydrolysis of cells in 10 mL of culture broth and derivatized by N-(tert-butyldimethylsilyl)-N-methyl-trifluoroacetamide containing 1% tert-butyldimethylchlorosilane. The MIDs of ion clusters of 24 fragments in Table 1 were determined by GC–MS (Agilent 7890 GC and Agilent 5975 MSD (Agilent Technologies). The MID data of [M-85]+ of leucine (Leu), [M-57] + and [M-85] + of glycine (Gly), [M-85]+ of serine (Ser), and [M-57] + and [M-157] + of glutamine (Gln) were not employed due to large standard deviations in the mass analysis. The effect of naturally occurring isotopes was removed from the raw mass spectrometry data to obtain corrected 13C-labeling patterns of the carbons in the amino acids (van Winden et al., 2002). The fluxes for biomass synthesis of E. coli were calculated from the precursor requirement. The standard deviations of MID measurements were set at 0.007. The metabolic flux distribution was estimated using the metabolic networks of E. coli consisting of glycolysis, pentose phosphate pathway, TCA cycle, anaplerotic pathway, glyoxylate pathway, and Entner-Doudoroff pathway (Supplementary data S4).
3. Results
3.1. Computer simulation of 13C-MFA of E. coli using [1-13C] and [U-13C]glucose
Various mixtures of non-labeled, [1-13C], and [U-13C]glucose such as 0:8:2, 0:5:5, and 5:3:2 have been widely employed in previous 13C-MFA studies of E. coli due to the commercial availability of [1-13C] and [U-13C]glucose (Crown and Antoniewicz, 2013). In this study, a computer simulation of 13C-MFA was conducted to investigate the relationship among the precision of metabolic flux estimation, compositions of [13C]glucose and the metabolic flux distribution (Fig. 1). This study considers the 13C-MFA of the central carbon metabolism in E. coli cultured in a medium containing glucose as sole carbon source, where the metabolic flux distribution at an isotopically steady state is estimated by a single labeling experiment using the MID data of the proteinous amino acids.
As mentioned in Section 1, the precision of estimated flux levels depends on the structure of the metabolic network model, composition of 13C-labeled glucose, available fragments of amino acids for the MID measurement, numbers of experiments, and the metabolic flux distribution of interest. Here, artificial MID data of 24 fragment ions of the amino acids in Table 1 were used throughout the study. These fragment ions are commonly employed among previous 13C-MFA studies (Antoniewicz et al., 2007a, Crown et al., 2015, Okahashi et al., 2014, Toya et al., 2010). The useful carbon sources were investigated from all patterns of non-labeled, [1-13C], and [U-13C]glucose mixtures with 10% step size (66 patterns in total). Furthermore, simulations of single labeling experiments were performed for five distinct metabolic flux distributions of E. coli (Fig. 2) determined from (A) a continuous culture of MG1655 (Okahashi et al., 2014), (B) a batch cultivation of MG1655 (Crown et al., 2015), (C) a batch cultivation of the pgiΔ deletion strain, (D) a batch cultivation of the pykΔ deletion strain (Toya et al., 2010), and (E) a batch cultivation of E. coli BW25113 (Toya et al., 2007). Metabolic models were also obtained from the literature (Fig. 2 and Supplementary data S1).
For example, the intracellular flux distribution, the glucose consumption, and product excretion rates of MG1655 under the continuous culture condition was obtained from the literature (Okahashi et al., 2014) (step 1 in Fig. 1). The composition of non-labeled, [1-13C], and [U-13C]glucose in the carbon source was arbitrarily set to 0:8:2 (step 2 in Fig. 1). A theoretical MID of [M-57]+ fragment for alanine (m/z 260–263) was calculated to be [0.38, 0.36, 0.12, 0.15] from the experimentally determined flux distribution (Fig. 1a), specific rates, (Fig. 1b), and the composition of carbon sources (Fig. 1c) (step 3). The theoretical MIDs were calculated for 24 fragments of the amino acids in Table 1, to which the Gaussian noise at 1% levels was added to produce artificially measured MID data (Fig. 1d). The metabolic flux distribution (Fig. 1e) and its 95% confidence intervals (Fig. 1f) were estimated by the procedure of 13C-MFA using artificial MID data (Fig. 1d) (step 4). Furthermore, an accuracy score Si (Fig. 1g) was determined for each reaction i, where a larger Si score indicates narrower 95% confidence interval or more precise estimation of flux level (see Material and Methods for detailed definition, step 5 in Fig. 1) (Metallo et al., 2009). In the case of the flux distribution of (A) with a glucose ratio at 0:8:2, the metabolic flux level and the 95% confidence interval of the reaction glucose-6-phosphate (G6P) -> 6-phosphogluconate (6PG) were estimated to be 24.6 and 23.5–27.7, respectively, from which SG6P ->6PG was determined to be 0.94. Finally, the sum of Si of all reactions Ssum was determined to be 23.24 (Fig. 1h). Here, the Ssum values were determined by this procedure for all 330 combinations of the mixtures of carbon sources and the five flux distributions (Fig. 3). In this study, the precision scores were determined from one replicate of the simulation since deviations of Ssum level (mean±standard deviation was estimated as 23.05±0.39 from 10 iterative simulations of the above procedure, for example) were smaller than the range of observed Ssum levels (approximately 14–24, Fig. 3).
Fig. 3a shows a heatmap representation of the Ssum levels determined for the five metabolic flux distributions. The red and blue colors represent larger (better precision) and smaller (poorer precision) Ssum scores of overall flux estimation, respectively. This result indicates that there are variations in Ssum levels depending on the carbon source mixtures and the metabolic flux distributions. For example, mixture ratios such as at 0:10:0 (100% [1-13C]glucose) and 5:0:5 (50% [U-13C]glucose) of non-labeled, [1-13C], and [U-13C]glucose showed smaller Ssum values for the flux distributions (C) and (D), respectively. On the other hand, the largest Ssum values were commonly observed for mixture ratios such as at 0:8:2 and 0:5:5. These results indicate that the mixture of 0:8:2 is suitable for a flux estimation of the whole metabolic network, at least for flux distributions similar to those examined in this study.
The precision scores of each reaction (Si) deduced by the computer simulation of the 13C-MFA of the flux distribution (A) are shown in Fig. 3b. The comparison of the Si levels indicates that the metabolic flux levels were more precisely determined for the reactions in glycolysis and the TCA cycle by many [13C]glucose mixtures. In contrast, the precision scores vary among the [13C]glucose mixtures for the cases of pentose phosphate pathway (PPP), anaplerotic, and the glyoxylate pathway reactions. For instance, the mixture ratios at 5:0:5 and 0:10:0 were less favorable than 0:8:2 and 0:5:5 due to poor precisions in the flux estimation of PPP and anaplerotic reactions. Furthermore, the mixture ratio at 4:1:5 is useful for the flux estimation of the isocitrate lyase (ICL) reaction in the glyoxylate pathway, since the precision score determined by the mixture ratio at 4:1:5 (SICL=0.93) was larger than that determined by the mixture ratio at 0:8:2 (SICL=0.87) (Fig. 3b). Similar trends were commonly observed among other flux distributions (Supplementary data S2 and 3). These results suggest that the selection of suitable carbon sources is important for the precise estimation of metabolic flux levels of PPP, anaplerotic, and glyoxylate pathway reactions in the 13C-MFA of E. coli using a mixture of non-labeled, [1-13C] and [U-13C]glucose.
3.2. Evaluation of all possible 13C-labeled types of glucose as carbon sources
A useful carbon source for the flux estimation of the PPP and the anaplerotic reactions was investigated by additional simulations of 13C-MFA to test all possible 13C-labeling patterns of glucose as a sole carbon source (Fig. 4 and Supplementary data S2 and S3). The simulation result showed that the largest sum of precision scores Ssum was observed when using [1, 2, 4-13C] and [1, 2-13C]glucose as carbon sources (Fig. 4a). The Ssum scores were similar or larger than those of the mixture ratio of non-labeled, [1-13C], and [U-13C]glucose at 0:8:2. In addition to the glycolysis and TCA cycle reactions, the 13C-MFA using [1, 2, 4-13C] and [1, 2-13C]glucose could precisely estimate the flux levels of PPP reactions for five flux distributions (Fig. 4b). The precision should be derived from the fact that three distinct isotopomers ([1, 2-13C], [1, 3-13C], and [3-13C]) of fructose-6-phosphate could be produced from [1, 2-13C]glucose through the Embden–Meyerhof-Parnas and two PP pathways, respectively (Supplementary Fig. S1). A previous computational analysis reported that [1, 2-13C]glucose was a better carbon source than the mixture ratio of non-labeled, [1-13C], and [U-13C]glucose at 0:8:2 (Schellenberger et al., 2012). This is probably because a Monte Carlo sampling of theoretically feasible flux distributions without evaluating the confidence intervals was employed for finding an optimal carbon source. Our results suggested that [1, 2, 4-13C] and [1, 2-13C]glucose are useful carbon sources for the precise flux estimation of the PPP. On the other hand, there are large variations in the precision scores of the flux estimation of the anaplerotic and glyoxylate pathway reactions, suggesting that the composition of carbon source affects the precisions scores by significantly interacting with the intracellular flux distributions.
3.3. Experimental confirmation by 13C-MFA of E. coli
The simulation of 13C-MFA showed that the mixture of non-labeled, [1-13C], and [U-13C]glucose at 0:8:2 is one of the best first choices for the precise flux analysis of the whole metabolic network of E. coli. It was also shown that the mixture ratio at 4:1:5 enabled a precise flux estimation specifically for the glyoxylate pathway. The findings were confirmed by wet 13C-MFA experiments. The wild type (MG1655) strain of E. coli was batch cultivated under aerobic conditions in M9 media containing non-labeled, [1-13C], and [U-13C]glucose at 0:8:2. The specific rates for cell growth, glucose consumption, and acetic acid production were determined to be 0.73±0.00 h−1, 8.91±0.53, and 4.05±0.41 mmol g-dry cell weight−1 h−1 from the time-course analysis of the medium composition (Supplementary data S5). No production of ethanol and other organic acids was observed. Following the sampling of E. coli cells at an exponential growth phase (OD600 ~1.0), MIDs of proteinous amino acids were determined by using the GC–MS (Supplementary data S4). Fig. 5A shows the metabolic flux distribution estimated from the MID and the material balance data. The residual sum of square (RSS) was 58.8, passing the χ2 test (Supplementary data S6).
The 13C-metabolic flux analysis was also performed by using medium containing non-labeled, [1-13C], and [U-13C]glucose at 4:1:5. Although essentially identical conditions were employed for this experiment, the estimated distribution was different from the above results in terms of the TCA cycle and PPP reactions (Fig. 5b, Supplementary data S4 and S6, RSS is 21.5 with a p-value of 0.999 by χ2 test). It was probably due to a slight difference in the aeration conditions between the two distinct experiments since the specific rates for cell growth, glucose consumption, and acetic acid production were 0.70±0.02 h−1, 8.13±0.76, and 4.14±0.18 mmol g-dry cell weight−1 h−1, respectively (Supplementary data S5).
The 95% confidence intervals of all reactions were determined by the grid search method (Fig. 5c, d, and Supplementary Fig. S2). The comparison showed that the 13C-MFA using the mixture ratio of 0:8:2 could more precisely estimate the metabolic flux levels of the reactions in the glycolysis since the 95% confidence intervals were narrower than those estimated by the mixture ratio at 4:1:5. For example, the 95% confidential intervals of phosphofructokinase (PFK) were determined to be 83.5–87.1 and 75.4–86.2 by using the mixtures of non-labeled, [1-13C], and [U-13C]glucose at 0:8:2 and 4:1:5, respectively (Fig. 5c). Similar results were observed for the PPP and TCA cycle reactions (Supplementary Fig. S2). On the other hand, narrower 95% confidence intervals of reactions related to the anaplerotic and glyoxylate pathways were observed for the mixture ratio at 4:1:5. For example, the 95% confidence interval of glyoxylate pathway flux (2.2–7.7) determined by the 4:1:5 mixture was narrower than that determined by the 0:8:2 mixture (0.1–8.8) (Fig. 5d). These results experimentally support the results of the computer simulation of 13C-MFA.
4. Discussion
The computer simulation of 13C-MFA experiments of E. coli was performed to investigate the relationship between the precision of metabolic flux estimation, composition of [13C]glucose and the metabolic flux distribution. The simulation results showed that the selection of carbon source mainly affected the precision of metabolic flux estimation of PPP, anaplerotic, and glyoxylate pathway reactions. This result also supports that, as has been proposed in previous studies, [1, 2-13C]glucose, and the mixture of non-labeled, [1-13C], and [U-13C]glucose at 0:8:2 are the most suitable carbon tracers for a precise estimation of flux levels of the PPP in addition to glycolysis and the TCA cycle (Crown et al., 2015, Shupletsov et al., 2014). The mixture of non-labeled, [1-13C], and [U-13C]glucose at 0:8:2 has been used for the 13C-MFA of E. coli (Fischer et al., 2004). The mixture is an affordable carbon source for the routine metabolic flux analysis due to the relatively lower cost of [1-13C]glucose (~$100/g) and [U-13C]glucose (~$200/g). However, it has been reported that the isotopic discrimination by microorganisms and isotopic impurities in13C-glucose could affect the result of 13C-MFA since E. coli metabolism selectively incorporates and utilizes light isotopes (Feng and Tang, 2011). The 13C-MFA using single 13C-glucose has an advantage in this regard, but requires more expensive carbon sources such as [1,2-13C]glucose ($500–$1000/g). [1, 2-13C]glucose has been employed for the precise metabolic flux analysis of E. coli (He et al., 2014), yeast (Wasylenko and Stephanopoulos, 2015), and the flux analysis of the PPP in plants (Nargund and Sriram, 2013). Although the generality has not been guaranteed, these carbon sources could be the best first choice for the 13C-MFA of E. coli since the results were confirmed by the simulation using five distinct metabolic flux distributions (Fig. 3, Fig. 4) and the wet 13C-MFA experiment of the batch cultivated E. coli (Fig. 5). The 13C-glucose should also be available to other microorganisms with similar metabolic pathways such as Bacillus subtilis and Corynebacterium glutamicum.
The results also revealed that there are large variations in the precisions scores of the anaplerotic and glyoxylate reactions among the flux distributions. It was predicted from the simulations that the mixture of non-labeled, [1-13C], and [U-13C]glucose at 4:1:5 was particularly effective for the flux estimation of the glyoxylate pathway reaction (Fig. 3b). Although the finding was confirmed by the wet experiment (Fig. 5), the carbon source could not be versatile enough for any flux distribution since the precision scores of the anaplerotic and glyoxylate pathway reactions are sensitively by both the carbon source and the flux distribution (Figs. 3b and 4b).
In addition to the 13C-MFA using the proteinogenic amino acids, the direct analysis of glycolytic intermediates by liquid chromatography (LC)-MS has been attempted to analyze mammalian cell cultures and non-growing microbial cells (Ahn and Antoniewicz, 2013, Metallo et al., 2009, Walther et al., 2012). The best 13C-labeled carbon source should be selected for each 13C-MFA experiment using glycolytic intermediates, with considering a list of the measurable intermediates under the physiological conditions of targeted cells. However, it is expected that [1, 2-13C]glucose or a mixture of [1-13C] and [U-13C]glucose at 8:2 are also useful carbon tracers. It is because the LC-MS analysis usually produces 13C-labeling data equivalent to the precursors of amino acids listed in Table 1 (pyruvate, 3-phosphoglycerate, phopshoenolpyruvate, erythrose-4-phosphate, oxaloacetate, and 2-ketoglutarate). Indeed, [1, 2-13C]glucose has been used for the metabolic flux analysis of cultured mammalian cells as an optimized 13C-labeled carbon source (Ahn and Antoniewicz, 2013, Metallo et al., 2009, Walther et al., 2012).
5. Conclusions
The present study suggests that 13C-MFA experiments should be designed considering an interaction among precision of flux estimation, carbon sources, and intracellular flux distributions. Following the 13C-MFA experiment using the first choice carbon tracers such as [1, 2-13C]glucose or a mixture of [1-13C] and [U-13C]glucose at 8:2, the best carbon tracer for the estimated metabolic flux distribution should be investigated by employing optimization methods such as EMU basis vectors (Crown and Antoniewicz, 2012) and Isodesign (Millard et al., 2014), when more precision is needed in the flux estimation of the anaplerotic and the glyoxylate pathways. Precise flux estimation would be attained by the second 13C-MFA employing an optimized single or parallel labeling experiments.
Acknowledgements
This research was partially supported by JST, Strategic International Collaborative Research Program, SICORP for JP-US Metabolomics, and a Grant in Aid for Scientific Research (C) No. 15K06579.
Footnotes
Supplementary data associated with this article can be found in the online version at 10.1016/j.meteno.2016.06.001.
Contributor Information
Kousuke Maeda, Email: kousuke_maeda@ist.osaka-u.ac.jp.
Nobuyuki Okahashi, Email: n-okahashi@ist.osaka-u.ac.jp.
Yoshihiro Toya, Email: ytoya@ist.osaka-u.ac.jp.
Fumio Matsuda, Email: fmatsuda@ist.osaka-u.ac.jp.
Hiroshi Shimizu, Email: shimizu@ist.osaka-u.ac.jp.
Appendix A. Supplementary material
.
.
References
- Ahn W.S., Antoniewicz M.R. Parallel labeling experiments with [1,2-13C]glucose and [U-13C]glutamine provide new insights into CHO cell metabolism. Metab. Eng. 2013;15:34–47. doi: 10.1016/j.ymben.2012.10.001. [DOI] [PubMed] [Google Scholar]
- Antoniewicz M.R. 13C metabolic flux analysis: optimal design of isotopic labeling experiments. Curr. Opin. Biotechnol. 2013;24:1116–1121. doi: 10.1016/j.copbio.2013.02.003. [DOI] [PubMed] [Google Scholar]
- Antoniewicz M.R. Using multiple tracers for 13C metabolic flux analysis. Methods Mol. Biol. 2013;985:353–365. doi: 10.1007/978-1-62703-299-5_17. [DOI] [PubMed] [Google Scholar]
- Antoniewicz M.R. Methods and advances in metabolic flux analysis: a mini-review. J. Ind. Microbiol. Biotechnol. 2015;42:317–325. doi: 10.1007/s10295-015-1585-x. [DOI] [PubMed] [Google Scholar]
- Antoniewicz M.R., Kelleher J.K., Stephanopoulos G. Determination of confidence intervals of metabolic fluxes estimated from stable isotope measurements. Metab. Eng. 2006;8:324–337. doi: 10.1016/j.ymben.2006.01.004. [DOI] [PubMed] [Google Scholar]
- Antoniewicz M.R., Kelleher J.K., Stephanopoulos G. Accurate assessment of amino acid mass isotopomer distributions for metabolic flux analysis. Anal. Chem. 2007;79:7554–7559. doi: 10.1021/ac0708893. [DOI] [PubMed] [Google Scholar]
- Antoniewicz M.R., Kelleher J.K., Stephanopoulos G. Elementary metabolite units (EMU): a novel framework for modeling isotopic distributions. Metab. Eng. 2007;9:68–86. doi: 10.1016/j.ymben.2006.09.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Arauzo-Bravo M.J., Shimizu K. An improved method for statistical analysis of metabolic flux analysis using isotopomer mapping matrices with analytical expressions. J. Biotechnol. 2003;105:117–133. doi: 10.1016/s0168-1656(03)00169-x. [DOI] [PubMed] [Google Scholar]
- Christen S., Sauer U. Intracellular characterization of aerobic glucose metabolism in seven yeast species by 13C flux analysis and metabolomics. FEMS Yeast Res. 2011;11:263–272. doi: 10.1111/j.1567-1364.2010.00713.x. [DOI] [PubMed] [Google Scholar]
- Costenoble R., Muller D., Barl T., van Gulik W.M., van Winden W.A., Reuss M., Heijnen J.J. 13C-Labeled metabolic flux analysis of a fed-batch culture of elutriated Saccharomyces cerevisiae. FEMS Yeast Res. 2007;7:511–526. doi: 10.1111/j.1567-1364.2006.00199.x. [DOI] [PubMed] [Google Scholar]
- Crown S.B., Antoniewicz M.R. Selection of tracers for 13C-metabolic flux analysis using elementary metabolite units (EMU) basis vector methodology. Metab. Eng. 2012;14:150–161. doi: 10.1016/j.ymben.2011.12.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Crown S.B., Antoniewicz M.R. Publishing 13C metabolic flux analysis studies: a review and future perspectives. Metab. Eng. 2013;20:42–48. doi: 10.1016/j.ymben.2013.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Crown S.B., Long C.P., Antoniewicz M.R. Integrated 13C-metabolic flux analysis of 14 parallel labeling experiments in Escherichia coli. Metab. Eng. 2015;28:151–158. doi: 10.1016/j.ymben.2015.01.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Feng X., Tang Y.J. Evaluation of isotope discrimination in 13C-based metabolic flux analysis. Anal. Biochem. 2011;417:295–297. doi: 10.1016/j.ab.2011.06.022. [DOI] [PubMed] [Google Scholar]
- Fischer E., Zamboni N., Sauer U. High-throughput metabolic flux analysis based on gas chromatography-mass spectrometry derived 13C constraints. Anal. Biochem. 2004;325:308–316. doi: 10.1016/j.ab.2003.10.036. [DOI] [PubMed] [Google Scholar]
- Gaglio D., Metallo C.M., Gameiro P.A., Hiller K., Danna L.S., Balestrieri C., Alberghina L., Stephanopoulos G., Chiaradonna F. Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth. Mol. Syst. Biol. 2011;7:523. doi: 10.1038/msb.2011.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Haverkorn van Rijsewijk B.R., Nanchen A., Nallet S., Kleijn R.J., Sauer U. Large-scale 13C-flux analysis reveals distinct transcriptional control of respiratory and fermentative metabolism in Escherichia coli. Mol. Syst. Biol. 2011;7:477. doi: 10.1038/msb.2011.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- He L., Xiao Y., Gebreselassie N., Zhang F., Antoniewiez M.R., Tang Y.J., Peng L. Central metabolic responses to the overproduction of fatty acids in Escherichia coli based on 13C-metabolic flux analysis. Biotechnol. Bioeng. 2014;111:575–585. doi: 10.1002/bit.25124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hiller K., Metallo C.M. Profiling metabolic networks to study cancer metabolism. Curr. Opin. Biotechnol. 2013;24:60–68. doi: 10.1016/j.copbio.2012.11.001. [DOI] [PubMed] [Google Scholar]
- Kajihata S., Furusawa C., Matsuda F., Shimizu H. OpenMebius: an open source software for isotopically nonstationary 13C-based metabolic flux analysis. Biomed. Res. Int. 2014;2014:627014. doi: 10.1155/2014/627014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leighty R.W., Antoniewicz M.R. COMPLETE-MFA: complementary parallel labeling experiments technique for metabolic flux analysis. Metab. Eng. 2013;20:49–55. doi: 10.1016/j.ymben.2013.08.006. [DOI] [PubMed] [Google Scholar]
- Metallo C.M., Walther J.L., Stephanopoulos G. Evaluation of 13C isotopic tracers for metabolic flux analysis in mammalian cells. J. Biotechnol. 2009;144:167–174. doi: 10.1016/j.jbiotec.2009.07.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Millard P., Sokol S., Letisse F., Portais J.C. IsoDesign: a software for optimizing the design of 13C-metabolic flux analysis experiments. Biotechnol. Bioeng. 2014;111:202–208. doi: 10.1002/bit.24997. [DOI] [PubMed] [Google Scholar]
- Nargund S., Sriram G. Designer labels for plant metabolism: statistical design of isotope labeling experiments for improved quantification of flux in complex plant metabolic networks. Mol. Biosyst. 2013;9:99–112. doi: 10.1039/c2mb25253h. [DOI] [PubMed] [Google Scholar]
- Okahashi N., Kajihata S., Furusawa C., Shimizu H. Reliable metabolic flux estimation in Escherichia coli central carbon metabolism using intracellular free amino acids. Metabolites. 2014;4:408–420. doi: 10.3390/metabo4020408. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Perez R.E., Jansen P.W., Martins J.R.R.A. pyOpt: a python-based object-oriented framework for nonlinear constrained optimization. Struct. Multidiscip. Optim. 2012;45:101–118. [Google Scholar]
- Schellenberger J., Zielinski D.C., Choi W., Madireddi S., Portnoy V., Scott D.A., Reed J.L., Osterman A.L., Palsson B. Predicting outcomes of steady-state 13C isotope tracing experiments using Monte Carlo sampling. BMC Syst. Biol. 2012;6:9. doi: 10.1186/1752-0509-6-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shimizu K. Metabolic flux analysis based on 13C-labeling experiments and integration of the information with gene and protein expression patterns. Adv. Biochem. Eng. Biotechnol. 2004;91:1–49. doi: 10.1007/b94204. [DOI] [PubMed] [Google Scholar]
- Shirai T., Fujimura K., Furusawa C., Nagahisa K., Shioya S., Shimizu H. Study on roles of anaplerotic pathways in glutamate overproduction of Corynebacterium glutamicum by metabolic flux analysis. Microb. Cell Factories. 2007;6:19. doi: 10.1186/1475-2859-6-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shupletsov M.S., Golubeva L.I., Rubina S.S., Podvyaznikov D.A., Iwatani S., Mashko S.V. OpenFLUX2: 13C-MFA modeling software package adjusted for the comprehensive analysis of single and parallel labeling experiments. Microb. Cell Factories. 2014;13:152. doi: 10.1186/s12934-014-0152-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Toya Y., Ishii N., Hirasawa T., Naba M., Hirai K., Sugawara K., Igarashi S., Shimizu K., Tomita M., Soga T. Direct measurement of isotopomer of intracellular metabolites using capillary electrophoresis time-of-flight mass spectrometry for efficient metabolic flux analysis. J. Chromatogr. A. 2007;1159:134–141. doi: 10.1016/j.chroma.2007.04.011. [DOI] [PubMed] [Google Scholar]
- Toya Y., Ishii N., Nakahigashi K., Hirasawa T., Soga T., Tomita M., Shimizu K. 13C-metabolic flux analysis for batch culture of Escherichia coli and its Pyk and Pgi gene knockout mutants based on mass isotopomer distribution of intracellular metabolites. Biotechnol. Prog. 2010;26:975–992. doi: 10.1002/btpr.420. [DOI] [PubMed] [Google Scholar]
- van Winden W.A., Wittmann C., Heinzle E., Heijnen J.J. Correcting mass isotopomer distributions for naturally occurring isotopes. Biotechnol. Bioeng. 2002;80:477–479. doi: 10.1002/bit.10393. [DOI] [PubMed] [Google Scholar]
- Walther J.L., Metallo C.M., Zhang J., Stephanopoulos G. Optimization of 13C isotopic tracers for metabolic flux analysis in mammalian cells. Metab. Eng. 2012;14:162–171. doi: 10.1016/j.ymben.2011.12.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wasylenko T.M., Stephanopoulos G. Metabolomic and 13C-metabolic flux analysis of a xylose-consuming Saccharomyces cerevisiae strain expressing xylose isomerase. Biotechnol. Bioeng. 2015;112:470–483. doi: 10.1002/bit.25447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wiechert W. 13C metabolic flux analysis. Metab. Eng. 2001;3:195–206. doi: 10.1006/mben.2001.0187. [DOI] [PubMed] [Google Scholar]
- Wittmann C. Fluxome analysis using GC–MS. Microb. Cell Factories. 2007;6:6. doi: 10.1186/1475-2859-6-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zamboni N., Fendt S.M., Ruhl M., Sauer U. 13C-based metabolic flux analysis. Nat. Protoc. 2009;4:878–892. doi: 10.1038/nprot.2009.58. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.